Get the Stockscreener App
42.47
0.54%
0.23
After Hours:
42.47
Harrow Inc stock is traded at $42.47, with a volume of 331.40K.
It is up +0.54% in the last 24 hours and down -16.07% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$42.24
Open:
$42.47
24h Volume:
331.40K
Relative Volume:
0.61
Market Cap:
$1.50B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-75.84
EPS:
-0.56
Net Cash Flow:
$-20.74M
1W Performance:
+0.07%
1M Performance:
-16.07%
6M Performance:
+137.40%
1Y Performance:
+366.70%
1-Day Range:
$41.79
$43.68
1-Week Range:
$40.60
$44.45
52-Week Range:
$8.7202
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
42.47 | 1.50B | 154.15M | -33.58M | -20.74M | -0.56 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
Harrow Inc Stock (HROW) Latest News
44,180 Shares in Harrow, Inc. (NASDAQ:HROW) Acquired by Penserra Capital Management LLC - MarketBeat
US Growth Stocks With High Insider Ownership To Watch - Simply Wall St
Connor Clark & Lunn Investment Management Ltd. Takes $5.86 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com South Africa
Harrow subsidiary wins $34.9 million in trademark case - Investing.com
Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX | HROW Stock News - StockTitan
HROW (Harrow) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Capex-to-Operating-Cash-Flow : 0.20 (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Investing : $4.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Receivables : $-35.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Inventory : $-1.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Total Inventories : $10.2 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow for Dividends : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Long-Term Debt & Capital Lease Obligation : $195.6 Mil (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Financing : $-1.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Operations : $4.3 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Operating Cash Flow per Share : $0.12 (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) PE Ratio without NRI : At Loss (As of Nov. 20, 2024) - GuruFocus.com
HROW (Harrow) Total Assets : $351.5 Mil (As of Sep. 2024) - GuruFocus.com
Former Harrow unit Melt announces results for MELT-300 to sedate for surgery - TipRanks
First Turn Management LLC Purchases New Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
28,177 Shares in Harrow, Inc. (NASDAQ:HROW) Purchased by Oppenheimer & Co. Inc. - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Stock Position Lessened by Royce & Associates LP - MarketBeat
Harrow Stock: Spotlight On IHEEZO (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 7.3%Here's Why - MarketBeat
Harrow Announces Participation in Upcoming Investor Conferences - BioSpace
Harrow Health, Inc. (NASDAQ:HROW) Q3 2024 Earnings Call Transcript - Insider Monkey
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Harrow Inc (HROW) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
Harrow Inc Com (HROW) Quarterly 10-Q Report - Quartzy
Harrow Grows Revenue 44 Percent in 2024 Third Quarter, Confirms Full-Year Guidance - Vision Monday
Harrow Inc. Reports Strong Q3 2024 Growth - TipRanks
Harrow (NASDAQ:HROW) Shares Gap DownWhat's Next? - MarketBeat
Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Q3 2024 Harrow Inc Earnings Call Transcript - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings: Revenue at $49.3M, Misses Es - GuruFocus.com
Los Angeles Capital Management LLC Sells 38,168 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow: Q3 Earnings Snapshot - New Haven Register
Harrow, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Harrow stock plunges 20% on weaker-than-expected Q3 earnings - MSN
Harrow stock plunges 20% on weaker-than-expected Q3 earnings (NASDAQ:HROW) - Seeking Alpha
Harrow (HROW) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
HROWHarrow, Inc. Latest Stock News & Market Updates - StockTitan
Harrow Q3 Revenue Surges 44% to $49.3M as VEVYE Prescriptions Jump 55% | HROW Stock News - StockTitan
Harrow Inc (HROW) Shares Up 6.99% on Nov 13 - GuruFocus.com
Harrow Inc (HROW) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
Harrow Partners with GoodRx, Cuts Prices on Key Eye Drug Portfolio | HROW Stock News - StockTitan
Harrow secures Medicare coverage for dry eye treatment VEVYE By Investing.com - Investing.com Canada
Harrow Inc (HROW) Stock Price Down 3.18% on Nov 12 - GuruFocus.com
Earnings Outlook For Harrow - Benzinga
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.83%
1.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):